The PE Ratio, or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). P/OP ratio Because P/E ratio is calculated using net income, the ratio can be sensitive to nonrecurring earnings and capital structure, analysts may use price to operating profit. The Price to Earnings Ratio (PE Ratio) is calculated by taking the stock price / EPS (ttm). Depending on the particular phase of a business cycle, some industries will perform better than others. The Price to Earnings Ratio (PE Ratio) is calculated by taking the stock price / EPS (ttm). AstraZeneca PE Ratio: 100.38 for July 21, 2020. 26.30: Price to Free Cash Flow -57.10: Cash Flow Per Share . By comparing a stock’s price per share to its earnings per share, we are able to see how much investors are paying for each dollar of the company’s earnings. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. One popular statistic used to identify such stocks is the PEG ratio - which is simply the Price Earnings ratio divided by the growth rate. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Astrazeneca Plc of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 29, 2021 - AZN, UPDATE 3-Ireland suspends Astrazeneca COVID-19 vaccine, Ireland recommends temporary deferral of Astrazeneca COVID-19 vaccine, AstraZeneca’s COVID-19 vaccine defended as more cases of blood clots emerge, SHAREHOLDER ALERT: CLSK AZN OTRK: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines, France raises prospect of mandatory Covid-19 jabs for healthcare staff, EU member states squabble over vaccine distribution. AstraZeneca's EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2020 was $1.22. Because of this, PE Ratio … AstraZeneca (GREY:AZNDF) PE Ratio Explanation The PE Ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. The shares are currently trading at SEK853.4. AstraZeneca PLC discovers, develops, manufactures, and commercializes prescription medicines in the areas of oncology, cardiovascular, renal and metabolism, respiratory, infection, neuroscience, and gastroenterology worldwide. Historical price to book ratio values for AstraZeneca (AZN) over the last 10 years. NYSE:AZN PE PEG Gauge Mar 18th 18. Get detailed AstraZeneca stock price news and analysis, Dividend, Bonus Issue, Quarterly results information, and more. UPDATE 1-S.Korea reports 3-week high 490 coronavirus cases, ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important March 29 Deadline – AZN, Astrazeneca (AZN) Stock Sinks As Market Gains: What You Should Know, U.S. reaches 100 million COVID-19 vaccine doses, Biden pledges vaccines open to all by May, RVshare sees 114% increase in bookings year-over-year, Lawsuits Filed Against Azn, Xom and Ebix - Jakubowitz Law Pursues Shareholders Claims, SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AstraZeneca PLC and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm, AstraZeneca to seek U.S. authorization within weeks: sources, Sotheby’s to auction off rare Macallan Whiskey bottles to benefit diversity, equity initiatives. Table 5 demonstrates PE ratio for both companies. The current price to book ratio for AstraZeneca as of March 11, 2021 is 8.36. The AstraZeneca PE ratio based on its reported earnings over the past 12 months is 52.47. This article is written for those who want to get better at using price to earnings ratios (P/E ratios). 1.83 ... Its 52-week range is between 36.15 and 64.94, which gives AZN stock a 52-week price range ratio of 45.57%. Historical price to book ratio values for AstraZeneca (AZN) over the last 10 years. View our latest analysis for AstraZeneca. The shares are currently trading at $49.27 . Compared to the aggregate P/E ratio of 62.86 in the Pharmaceuticals industry, AstraZeneca Inc. has a higher P/E ratio of 65.96. Browse... View Full Chart PE Ratio Chart . AstraZeneca current ratio for the three months ending December 31, 2020 was 0.96 . AstraZeneca has a P/E ratio of 39.02, based on the last twelve months. In depth view into AstraZeneca PE Ratio (Forward 1y) including historical data from 1993, charts, stats and industry comps. It is calculated by dividing a company's price per share by its earnings per share. Sign in. Currently, AstraZeneca has a PEG ratio of 1.43 compared to the Large Cap Pharmaceuticals industry's PEG ratio of 1.89. There is no data for the selected date range. NSE Gainer-Large Cap . In depth view into AstraZeneca PE Ratio (Annual) including historical data from 1993, charts, stats and industry comps. During the past 13 years, AstraZeneca's highest PE Ratio without NRI was 99.64. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. The Price to Earnings Ratio (PE Ratio) is calculated by taking the stock price / EPS (ttm). Check out why AstraZeneca share price is up today. There is no data for the selected date range. Therefore, AstraZeneca's PE Ratio without NRI ratio for today is 39.14. AstraZeneca EPS for the quarter ending December 31, 2020 was $0.39, a 226.67% increase year-over-year. There isn't necesarily an optimum PE ratio, since different industries will have different ranges of PE Ratios. PE Ratio . AstraZeneca PLC’s P/E ratio increased from 2012 to 2013 and from 2013 to 2014. 8.08: PS Ratio . View and export this data going back to 1993. There isn't necesarily an optimum PE ratio, since different industries will have different ranges of PE Ratios. Export Data Save Image Print Image For advanced charting, view our full-featured Fundamental Chart. The forward P/E ratio is a current stock's price over its "predicted" earnings per share. Because of this, PE Ratio is great to evaluate from a relative standpoint with other similar companies. The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share.As of today, AstraZeneca's share price is $48.060000.AstraZeneca's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2020 was $10.14.Hence, AstraZeneca's PS Ratio for today is 4.74.. Good Sign: AstraZeneca key facts Price/Earnings ratio: 20.8 Trading at 48.3% below our estimate of its fair value. About PE Ratio (TTM) AstraZeneca has a trailing-twelve-months P/E of 23.86X compared to the Large Cap Pharmaceuticals industry's P/E of 12.77X. AstraZeneca 2020 annual EPS was $1.22, a 134.62% increase from 2019. If we look at the PE ratio, we find that AstraZeneca PLC’s ratio stands at 54.78 compared to Johnson & Johnson’s 26.86 and Novartis Ag’s 30.08. Nifty 15,174.80 76.4. Please try again by refreshing your browser or contact us with details of your problem. There's also the risk that a rival bidder appears out of the woodwork - given Alexion's relatively modest PE ratio that shouldn't be ruled out. More Details. Earnings are forecast to grow 22.1% per year. Find a Symbol Search for Price/Earnings & PEG Ratios When autocomplete results are available use up and down arrows to review and enter to select. AstraZeneca share price live updates on The Economic Times. AstraZeneca Quick Ratio Historical Data; Date Current Assets - Inventory Current Liabilities Quick Ratio; 2020-12-31: $15.52B: $20.31B: 0.76: 2020-09-30: $14.48B The Forward Price to Earnings (PE) Ratio is similar to the price to earnings ratio. 12/02/2021 08:31:22 1 … Shareholders can employ the PER in order to estimate the target’s total equity value by re-estimating future earnings and multiplying them with benchmark PE-ratios (Sudarsanam, 2010, p. 429). 12.6 1289 102.1 0 2012 9.5 2,909.5 306. The AstraZeneca PE ratio based on its reported earnings over the past 12 months is 51.05. Price to Earnings Ratio (PE Ratio) Definition. AstraZeneca PLC’s P/OP ratio increased from 2012 to 2013 and from 2013 to 2014. During five years of share price growth, AstraZeneca achieved compound earnings per share (EPS) growth of 1.0% per year. Stock analysis for AstraZeneca PLC (AZN:London) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Includes annual, quarterly and trailing numbers with full history and charts. An error occurred. This metric is considered a valuation metric that confirms whether the earnings of a company justifies the stock price. As of today (2021-03-11), AstraZeneca's share price is £71.920000. Current and historical current ratio for AstraZeneca (AZN) from 2006 to 2020. Price to Earnings Ratio (PE Ratio) Definition. Financial ratios and metrics for AstraZeneca stock (AZN). An error occurred. This metric is considered a valuation metric that confirms whether the earnings of a company justifies the stock price. AstraZeneca's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2020 was £1.90. The company's trailing twelve month (TTM) PEG ratio is the P/E ratio … The regular P/E ratio is a current stock price over its earnings per share. Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Benchmarks . The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. Sign in. The AstraZeneca PE ratio based on its reported earnings over the past 12 months is 52.71. Rewards. 5.17: Price to Cash Flow . There isn't necesarily an optimum PE ratio, since different industries will have different ranges of PE Ratios. If we look at the PE ratio, we find that AstraZeneca PLC’s ratio stands at 39.99 compared to Johnson & Johnson’s 29.47 and Eli Lilly and Company’s 30.23. UPDATE 1-S.Korea reports 3-week high 490 coronavirus cases, ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important March 29 Deadline – AZN, Astrazeneca (AZN) Stock Sinks As Market Gains: What You Should Know, U.S. reaches 100 million COVID-19 vaccine doses, Biden pledges vaccines open to all by May, RVshare sees 114% increase in bookings year-over-year, Lawsuits Filed Against Azn, Xom and Ebix - Jakubowitz Law Pursues Shareholders Claims, SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AstraZeneca PLC and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm, AstraZeneca to seek U.S. authorization within weeks: sources, Sotheby’s to auction off rare Macallan Whiskey bottles to benefit diversity, equity initiatives. The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. P/S ratio An rationale for the P/S ratio is that sales, as the top line in an income statement, are generally less subject to distortion or manipulation than other fundamentals such as EPS or book value. In other words, at today's prices, investors are paying £39.02 for every £1 in prior year profit. Already a subscriber? AstraZeneca EPS for the twelve months ending December 31, 2020 was $1.22, a 134.62% increase year-over-year. AstraZeneca Inc. has a better P/E ratio of 69.2 than the aggregate P/E ratio of 15.46 of the Drug Manufacturers—General industry. Price to … The Price to Earnings Ratio (PE Ratio) is calculated by taking the stock price / EPS (ttm). Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the … Please try again by refreshing your browser or contact us with details of your problem. Demystifying the P/E ratio. The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. The shares are currently trading at 7192p. Was AstraZeneca Smart to Sell Its Moderna Shares? The current price to book ratio for AstraZeneca as of March 11, 2021 is 8.36 . Elsewhere, the overall performance for the S&P 500 and Dow Jones Industrial shows that the indexes are up 1.94% and 1.86% respectively on the day as seen in early trades. Sign in. PE Ratio: Yield: 52-Wks-Range: 96,543.06: 1,311.90 -1.14: 74.58: 211.13: 98.68: 2.87: 10,120.00 - 5,871.00 Already a subscriber? 14.6 1618 110.5 4 2.5.3. Dividend cover Figure 16 shows that dividend cover figure for GSK and AstraZeneca between 2009 and 2013. This metric is considered a valuation metric that confirms whether the earnings of a company justifies the stock price. A common ratio used for relative valuation is the P/E ratio. There isn't necesarily an optimum PE ratio, since different industries will have different ranges of PE Ratios. Already a subscriber? We'll apply a basic P/E ratio analysis to AstraZeneca PLC's (), to help you decide if the stock is worth further research.AstraZeneca has a P/E ratio of 39.02, based on the last twelve months.In other words, at today's prices, investors are paying £39.02 for every £1 in prior year profit. Forward PE Ratio Definition. In other words, at today's prices, investors are paying £39.02 for every £1 in prior year profit. However in 2013 AstraZeneca’s P/E ratio increased significantly and was almost twice as GSK’s. The PE Ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Historical PE Ratio Data. This metric is considered a valuation metric that confirms whether the earnings of a company justifies the stock price. Astral Poly Tech 2,501.60 153.05. For a detailed definition, formula and example for Price/Book Ratio, check out our new background page here. View and export this data going back to 1993. It is calculated by dividing a company's price per share by its earnings per share. Because of this, PE Ratio is great to evaluate from a relative standpoint with other similar companies. View and export this data going back to 1993. Was AstraZeneca Smart to Sell Its Moderna Shares? As can be seen from the table, GSK’s ratio was higher than AstraZeneca’s in 2011 and 2012. Because of this, PE Ratio is great to evaluate from a … SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Astrazeneca Plc of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 29, 2021 - AZN, UPDATE 3-Ireland suspends Astrazeneca COVID-19 vaccine, Ireland recommends temporary deferral of Astrazeneca COVID-19 vaccine, AstraZeneca’s COVID-19 vaccine defended as more cases of blood clots emerge, SHAREHOLDER ALERT: CLSK AZN OTRK: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines, France raises prospect of mandatory Covid-19 jabs for healthcare staff, EU member states squabble over vaccine distribution. AstraZeneca 2019 annual EPS was $0.52, a 38.82% decline from 2018. Formula. Compared to the aggregate P/E ratio of 15.15 in the Pharmaceuticals industry, AstraZeneca Inc. has a higher P/E ratio of 67.88. If the forward P/E ratio is higher than the current P/E ratio… 39.40: PB Ratio . About PE Ratio (TTM) AstraZeneca has a trailing-twelve-months P/E of 23.63X compared to the Large Cap Pharmaceuticals industry's P/E of 12.99X. The lowest was 6.03. AstraZeneca current ratio for the three months ending December 31, 2020 was 0.96 . P/E ratio for AstraZeneca and GSK (2011-2013) AZ GSK Years PE Market EPS PE Market EPS ratio price ratio price share share 2011 6.4 2,975.0 464. AstraZeneca (GREY:AZNDF) PE Ratio Explanation. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio is 15. Astrazeneca Plc financial information, fundamentals, key ratios, market capitalization, shares outstanding, float, and short interest. Find a Symbol Search for Price/Earnings & PEG Ratios When autocomplete results are available use up and down arrows to review and enter to select. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio is 15. AstraZeneca Quick Ratio Historical Data; Date Current Assets - Inventory Current Liabilities Quick Ratio; 2020-12-31: $15.52B: $20.31B: 0.76: 2020-09-30: $14.48B View 4,000+ financial data types. Price to Earnings Ratio or P/E is price / earnings. Current and historical current ratio for AstraZeneca (AZN) from 2006 to 2020. 15.8 1422 90.2 3 2013 28.7 3,574.5 124. Elsewhere, the overall performance for the S&P 500 and Dow Jones Industrial shows that the indexes are down -0.36% and 0.41% respectively on the day as seen in early trades. For advanced charting, view our full-featured.
F1 2021 Ea Sports, Restaurant Bad Urach, Farbring Pyramide Holz, Handball 3 Liga Hessen, Mazedonien Mit Euro Bezahlen, Carsten Jancker Jung, Glendower Pro Shop, Torwart Trikot Kurzarm, Handball Harz Wiki, Semaglutide Cost Canada,